Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
(NY:
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about
< Previous
1
2
3
4
5
6
7
8
9
...
36
37
Next >
BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball
April 01, 2021
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a COVID-19 testing agreement for players and staff, stadium employees and league staff for the 2021 Major League...
From
PR Newswire
BioReference Laboratories Expands COVID-19 School Testing Program
March 26, 2021
BioReference is currently testing students and staff from two of the five largest school districts in the nation and is prepared to rapidly expand COVID-19 school testing to other school districts...
From
PR Newswire
Diagnostic Improvements Play a Key Role in the Abatement of the Pandemic
March 23, 2021
- FinancialBuzz.com News Commentary
From
PR Newswire
EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
February 26, 2021
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorization Application (MAA) for...
From
Business Wire News Releases
New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy
February 22, 2021
Locations now open in NYC with more to follow across the State
From
PR Newswire
OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
February 18, 2021
Conference call begins at 4:30 p.m. Eastern time today
From
GlobeNewswire News Releases
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021
February 03, 2021
From
GlobeNewswire News Releases
New Drug Application Submitted to PMDA in Japan for Somatrogon, to Treat Pediatric Patients with Growth Hormone Deficiency
January 28, 2021
From
GlobeNewswire News Releases
OPKO Health's GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia
January 26, 2021
GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched several new genetic tests, including repeat expansion analysis for...
From
PR Newswire
OPKO Health's BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing
January 26, 2021
BioReference executes COVID-19 testing program for NBA and NHL for 2020-21 seasons, as well as U.S. Women's and Men's National Soccer Teams, Winter X Games and NBA G League
From
PR Newswire
OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access
January 13, 2021
Scarlet brings diagnostic service to patients' homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers
From
PR Newswire
Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q’20 Guidance
January 13, 2021
Calls on Analysts and Stockholders Attending J.P. Morgan’s Healthcare Conference to Determine Whether Management Disputes our Analysis and Stands by Original 4Q’20 Guidance
From
GlobeNewswire News Releases
OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021
From
GlobeNewswire News Releases
OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide
January 04, 2021
Nearly 210,000 New York City students, teachers, principals and staff were tested by BioReference with a positivity rate of 0.47%
From
PR Newswire
US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
January 04, 2021
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the US Food and Drug Administration (FDA) has accepted for filing the initial Biologics License Application (BLA) for...
From
Business Wire News Releases
Buffalo Bills and OPKO Health's BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program
December 31, 2020
The Bills leverage testing capabilities from NFL testing provider, BioReference, to initiate fan testing program
From
PR Newswire
OPKO Health Appoints Dr. Roger Medel to its Board of Directors
December 21, 2020
From
GlobeNewswire News Releases
A New Surge in Cases Emphasizes the Need for Effective Diagnostics
December 02, 2020
- FinancialBuzz.com News Commentary
From
PR Newswire
Sian Capital Sends Letter to OPKO Health Regarding its Decision to Apparently Withhold Rayaldee From Many Patients Amidst COVID-19’s Second Wave
November 20, 2020
From
GlobeNewswire News Releases
The Need for Precise Testing Capabilities is Clear as Cases Surge
November 19, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Sian Capital Issues Open Letter to Stockholders of OPKO Health
November 12, 2020
From
GlobeNewswire News Releases
OPKO Health to Participate in Three Upcoming Investment Conferences
November 11, 2020
From
GlobeNewswire News Releases
New Disinfection Technology and Wide Range of PPEs Emerge at a Time of Need
November 05, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Sian Capital Highlights Paths to Meaningful Value Creation at OPKO Health
October 29, 2020
From
GlobeNewswire News Releases
OPKO Health Reports 2020 Third Quarter Business Highlights and Financial Results
October 29, 2020
Conference call begins at 4:30 p.m. Eastern time today
From
GlobeNewswire News Releases
OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test
October 20, 2020
New offering identifies COVID-19 and Influenza infections with a single sample
From
PR Newswire
More Stringent Testing is Planned in a Bid to Return to Normalcy
October 14, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
OPKO Health to Report Third Quarter 2020 Financial Results on October 29, 2020
October 13, 2020
From
GlobeNewswire News Releases
OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools
October 09, 2020
Through New York City, BioReference will be testing students, teachers and staff in nearly 1,000 NYC public schools
From
PR Newswire
Notice of Class Action Settlement Involving Purchasers of OPKO Health, Inc. Common Stock during the period of September 26, 2013 through September 7, 2018
October 08, 2020
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
36
37
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.